📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden. (2016)

First Author: Verhoef TI

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/tpj.2016.41

PubMed Identifier: 27272045

Publication URI: http://europepmc.org/abstract/MED/27272045

Type: Journal Article/Review

Volume: 16

Parent Publication: The pharmacogenomics journal

Issue: 5

ISSN: 1470-269X